Spine company earns $150M equity funding

Saluda Medicine, which is behind the Evoke spinal cord stimulation system, received a $150 million equity financing round, the company said April 13.

Advertisement

The funding round was led by Wellington Management, according to a news release. The proceeeds will be used to push the commercial launch of Evoke.

The company also redomiciled as Saluda Medical Inc., a Delaware company. the release said.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.